Curriculum
2.50 CME Credit
Meeting Migraine Head-On: Novel Approaches to Acute and Preventive Therapy
Program description to come
CME Information
2.50 AMA PRA Category 1 Credits, 2.50 ABIM MOC or 2.87 AANP, including 1.95 AANP Pharm
Release Date: 7/1/2022
Available for credit until 12/15/2023
Learning Objectives
- Discuss the triage and work-up of patients with headache, including validated tools and guidelines that aid in diagnosing suspected migraine.
- Identify patients who are candidates for preventive migraine therapy.
- Demonstrate the use and limitations of traditional approaches to acute and preventive migraine management.
- Employ new migraine-specific agents for both treatment of acute attacks and prevention.
- Individualize migraine care plans to ensure that each patient’s unique needs are addressed, ultimately improving symptoms and quality of life.
Courses
Podcast
Your Questions About Migraine Answered
0.25 CME/MOC
0.29 AANP | 0.10 Pharmacology
Podcast
The Case of a Patient with Migraine and Cardiovascular Disease
0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology
Podcast
Your Questions About Migraine Work-Up And Prevention Answered
0.25 CME/MOC
0.36 AANP | 0.12 Pharmacology
Podcast
Proving Cassandra Wrong: The Case For Migraine Prevention
0.25 CME/MOC
0.28 AANP | 0.19 Pharmacology
Virtual CME Program
Meeting Migraine Management Head-On: Novel Approaches to Acute and Preventive Therapy
1.00 CME/MOC
1.00 AANP | 0.60 Pharmacology
Podcast
Your Questions About Migraine Treatment Answered
0.25 CME/MOC
0.35 AANP | 0.35 Pharmacology
Podcast
What To Do When Traditional Migraine Treatments Don’t Work: A Case Study
0.25 CME/MOC
0.34 AANP | 0.34 Pharmacology
Faculty
Dawn C. Buse, PhD
Clinical Professor, Department of Neurology, Albert Einstein College of Medicine of Yeshiva University
Licensed Psychologist
Fellow, American Headache Society
Pamela Kushner, MD, FAAFP
Clinical Professor
University of California Irvine Medical Center
Director
Kushner Wellness Center
Los Alamitos, CA
Supporters and Partners
Commercial Supporter
Biohaven Pharmaceuticals
Education Partner
Pri-Med Institute
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
Meeting Migraine Head-On: Novel Approaches to Acute and Preventive Therapy
Learning Objectives
- Discuss the triage and work-up of patients with headache, including validated tools and guidelines that aid in diagnosing suspected migraine
- Identify patients who are candidates for preventive migraine therapy
- Demonstrate the use and limitations of traditional approaches to acute and preventive migraine management
- Employ new migraine-specific agents for both treatment of acute attacks and prevention
- Individualize migraine care plans to ensure that each patient’s unique needs are addressed, ultimately improving symptoms and quality of life